Cresco Labs (OTCMKTS:CRLBF), Inc. (OTCMKTS:CRLBF) is a leading vertically integrated cannabis operator in the United States. Founded in 2013 and headquartered in Chicago, the company manages the entire cannabis supply chain from cultivation and extraction to product manufacturing and retail distribution. Cresco Labs is structured to deliver a broad range of cannabis offerings to consumers while maintaining regulatory compliance in each state it serves.
The company’s core business activities encompass cultivating premium cannabis flower, producing oils and concentrates, and formulating a diverse portfolio of branded consumables. Under its flagship brands—such as Cresco, Reserve, and Good News—the company offers products that include pre-rolls, vape cartridges, edibles, and topicals. Cresco Labs also operates Sunnyside dispensaries, a consumer-focused retail banner designed to provide an upscale, consistent shopping experience.
With licenses and operations spanning numerous states—including Illinois, California, Massachusetts, Florida, Pennsylvania and Michigan—Cresco Labs has built one of the largest footprints in the U.S. cannabis market. Through strategic acquisitions, such as the purchase of Origin House and VidaCann, the company has strengthened its wholesale distribution network and expanded its ability to serve both medical and adult-use markets. Cresco Labs’ infrastructure includes state-of-the-art cultivation facilities, a manufacturing campus in Naperville, Illinois, and a robust logistics framework that supports seamless supply across licensed markets.
Leadership at Cresco Labs is spearheaded by co-founder and CEO Charlie Bachtell, whose experience in both the financial and cannabis sectors has guided the company’s rapid growth. The executive team combines expertise in regulatory affairs, agriculture, manufacturing and retail operations, with a strong emphasis on compliance, sustainability and community engagement. Cresco Labs continues to prioritize research and development, aiming to innovate new delivery methods and product formulations that address consumer preferences and medical needs.
